Anders Miki Bojesen

Open Access Cyrielle Fougeroux, Louise Turner, Anders Miki Bojesen, Thomas Lavstsen and Peter Johannes Holst J Immunol April 15, 2019, 202 (8) 2320-2331; DOI: https://doi.org/10.4049/jimmunol.1801210 Abstract Adenoviral vectors can induce T and B cell immune responses to Ags encoded in the recombinant vector. The MHC class II invariant chain (Ii) has been used as an adjuvant to enhance T cell responses to tethered Ag encoded in adenoviral vectors.

Open Access Cyrielle Fougeroux, Louise Turner, Anders Miki Bojesen, Thomas Lavstsen and Peter Johannes Holst J Immunol March 4, 2019, ji1801210; DOI: https://doi.org/10.4049/jimmunol.1801210 Abstract Adenoviral vectors can induce T and B cell immune responses to Ags encoded in the recombinant vector. The MHC class II invariant chain (Ii) has been used as an adjuvant to enhance T cell responses to tethered Ag encoded in adenoviral vectors.

To assess whether or not any of the vaccine formulations influenced the fitness or condition of the fish, Fultons condition factor was calculated and recorded for a sampled subset of each group at three different time points. Comparing the groups within each sampling time point, only the CpG-formulation displayed a statistically significant difference from the naïve control group, as well as the bacterin group at three weeks post vaccination (Fig. 1).